semaglutide loss of exclusivity Ozempic, Wegovy and Rybelsus: The patents behind Novo Nordisk's weight-loss drugs The outlook for obesity from

They are given by injections

Cross-sectional and longitudinal assessment of aortic root dilation and valvular anomalies in hypermobile and classic EhlersDanlos syndrome

What the draft recommendation says The Canada's Drug Agency (CDA) draft, published in the spring of 2026, gave tirzepatide a generally positive review and suggested public plans treat it similarly to semaglutide [Source: theglobeandmail.com/business/economy/article-canada-drug-agency-mounjaro-recommendation-type-2-diabetes/]

Talk to your healthcare provider to see if you are an ideal candidate for these drugs

Sleep optimization When your body is running on fewer calories and adapting to new metabolic signals, sleep quality becomes even more critical than usual

Semaglutide for Obesity and Weight Loss As a weight loss drug, semaglutide has been shown to substantially reduce body weight in individuals with obesity